152 related articles for article (PubMed ID: 6602709)
21. Il-4 is an endogenous T cell growth factor during the immune response to a syngeneic retrovirus-induced tumor.
Kern DE; Peace DJ; Klarnet JP; Cheever MA; Greenberg PD
J Immunol; 1988 Oct; 141(8):2824-30. PubMed ID: 2459230
[TBL] [Abstract][Full Text] [Related]
22. Mouse alloantibodies capable of blocking cytotoxic T cell function. V. The majority of I region-specific CTL are Lyt-2+ but are relatively resistant to anti-Lyt-2 blocking.
Shinohara N; Kojima M
J Immunol; 1984 Feb; 132(2):578-83. PubMed ID: 6197465
[TBL] [Abstract][Full Text] [Related]
23. Antibodies to nonpolymorphic determinants of the Thy-1 molecule inhibit T cell proliferation.
Hollander N
J Immunol; 1985 May; 134(5):2916-21. PubMed ID: 2858507
[TBL] [Abstract][Full Text] [Related]
24. Signal requirements for the in vitro differentiation of cytotoxic T lymphocytes (CTL): distinct soluble mediators promote preactivation of CTL-precursors, clonal growth and differentiation into cytotoxic effector cells.
Hardt C; Diamantstein T; Wagner H
Eur J Immunol; 1985 May; 15(5):472-8. PubMed ID: 3158532
[TBL] [Abstract][Full Text] [Related]
25. The role of tumor-specific Lyt-1+2- T cells in eradicating tumor cells in vivo. I. Lyt-1+2- T cells do not necessarily require recruitment of host's cytotoxic T cell precursors for implementation of in vivo immunity.
Fujiwara H; Fukuzawa M; Yoshioka T; Nakajima H; Hamaoka T
J Immunol; 1984 Sep; 133(3):1671-6. PubMed ID: 6205091
[TBL] [Abstract][Full Text] [Related]
26. Studies on the mechanism of suppression of primary cytotoxic responses by cloned cytotoxic T lymphocytes.
Fink PJ; Rammensee HG; Benedetto JD; Staerz UD; Lefrancois L; Bevan MJ
J Immunol; 1984 Oct; 133(4):1769-74. PubMed ID: 6236258
[TBL] [Abstract][Full Text] [Related]
27. Lyt-2+ cells. Requirements for concanavalin A-induced proliferation and interleukin 2 production.
Kern DE; Lachmann LB; Greenberg PD
J Immunol; 1987 Nov; 139(9):2880-7. PubMed ID: 2959723
[TBL] [Abstract][Full Text] [Related]
28. Effects of monoclonal antibodies directed against murine T lymphocyte cell surface antigens on lymphokine production by cloned T lymphocytes reactive with class I MHC or Mls alloantigens.
Lancki DW; Prystowsky MB; Vogel SN; Beller DI; Dialynas DP; Fitch FW
J Immunol; 1984 Oct; 133(4):2051-7. PubMed ID: 6236262
[TBL] [Abstract][Full Text] [Related]
29. Activation of Lyt-2+ T cells by antibodies towards brain-associated antigens. II. Antibody-dependent induction of "nonspecific" cell-mediated cytotoxicity.
Gullberg M; Coutinho A
Eur J Immunol; 1985 Oct; 15(10):971-6. PubMed ID: 3876942
[TBL] [Abstract][Full Text] [Related]
30. Induction and blocking of cytolysis in CD2+, CD3- NK and CD2+, CD3+ cytotoxic T lymphocytes via CD2 50 KD sheep erythrocyte receptor.
Bolhuis RL; Roozemond RC; van de Griend RJ
J Immunol; 1986 Jun; 136(11):3939-44. PubMed ID: 3084649
[TBL] [Abstract][Full Text] [Related]
31. Heterologous cross-linking of Lyt-2 (CD8) to the alpha beta-T cell receptor is more effective in T cell activation than homologous alpha beta-T cell receptor cross-linking.
Boyce NW; Jönsson JI; Emmrich F; Eichmann K
J Immunol; 1988 Nov; 141(9):2882-8. PubMed ID: 3262671
[TBL] [Abstract][Full Text] [Related]
32. Studies on the cytolytic attack mechanism of the cytotoxic T lymphocyte (CTL): preparation of antisera against cellfree cytosolic extracts of a CTL clone capable of blocking the lethal hit stage of CTL cytolysis and analysis of the cytolytic structure.
Hiserodt JC
J Immunol; 1985 Jul; 135(1):53-62. PubMed ID: 3158707
[TBL] [Abstract][Full Text] [Related]
33. Search for class II major histocompatibility complex molecular involvement in the response of Lyt-2+ cytotoxic T lymphocyte precursors to alloantigen.
Romani L; Mage MG
Eur J Immunol; 1985 Nov; 15(11):1125-30. PubMed ID: 2933265
[TBL] [Abstract][Full Text] [Related]
34. Functional analysis of T cell subsets from mice bearing the lpr gene.
Davignon JL; Budd RC; Ceredig R; Piguet PF; MacDonald HR; Cerottini JC; Vassalli P; Izui S
J Immunol; 1985 Oct; 135(4):2423-8. PubMed ID: 3928747
[TBL] [Abstract][Full Text] [Related]
35. On the role of I-A antigens in lectin- and antigen-induced interleukin 2 production.
Larsson EL; Coutinho A
Eur J Immunol; 1984 May; 14(5):431-5. PubMed ID: 6233158
[TBL] [Abstract][Full Text] [Related]
36. Lymphokine-induced cytotoxicity: requirement of two lymphokines for the induction of optimal cytotoxic response.
Yang SS; Malek TR; Hargrove ME; Ting CC
J Immunol; 1985 Jun; 134(6):3912-9. PubMed ID: 3921614
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of helper function with anti-Lyt-2 or anti-L3T4 monoclonal antibodies depending on stimulating antigens.
Guimezanes A; Schmitt-Verhulst AM
Eur J Immunol; 1985 Dec; 15(12):1187-91. PubMed ID: 2935405
[TBL] [Abstract][Full Text] [Related]
38. Studies on the induction and expression of T cell-mediated immunity. XV. Role of non-MHC papain-sensitive target structures and Lyt-2 antigens in allogeneic and xenogeneic lectin-dependent cellular cytotoxicity (LDCC).
Bonavida B; Katz J
J Immunol; 1985 Sep; 135(3):1616-23. PubMed ID: 3874903
[TBL] [Abstract][Full Text] [Related]
39. Activation of Lyt-2+ (CD8+) and L3T4+ (CD4+) T cell subsets by anti-receptor antibody.
Hathcock KS; Segal DM; Hodes RJ
J Immunol; 1989 Apr; 142(7):2181-6. PubMed ID: 2784455
[TBL] [Abstract][Full Text] [Related]
40. CD4 and CD8 accessory molecules function through interactions with major histocompatibility complex molecules which are not directly associated with the T cell receptor-antigen complex.
Lustgarten J; Waks T; Eshhar Z
Eur J Immunol; 1991 Oct; 21(10):2507-15. PubMed ID: 1915555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
